by mediaid pharmacy | Jan 1, 2026 | Blogs
In the evolving landscape of antiviral therapies used in hospital-based oncology and infectious disease management, Pandovir 100 mg has emerged as a widely recognized Remdisivir injection. Manufactured under strict pharmaceutical quality standards, Pandovir Injection...
by mediaid pharmacy | Dec 26, 2025 | Blogs
Olaparib 150 mg is an innovative cancer treatment that provides hope to patients diagnosed with ovarian, breast, and pancreatic cancers, particularly those with BRCA1 or BRCA2 gene mutations. As part of the class of drugs known as PARP inhibitors, Olaparib works by...
